Clinical trial
Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain Management: a Double-blind, Randomized, Three Arm, Placebo Controlled Trial Assessing the Key Non-opioids Dipyrone (Metamizole) and Ibuprofen
NCT07682558 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain Management: a Double-blind, Randomized, Three Arm, Placebo Controlled Trial Assessing the Key Non-opioids Dipyrone (Metamizole) and Ibuprofen
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- November 30, 2029
- Enrollment
- 318 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer pain, cancer palliative care